Jesús Molina

775 total citations
7 papers, 188 citations indexed

About

Jesús Molina is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Jesús Molina has authored 7 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 1 paper in Infectious Diseases and 1 paper in Surgery. Recurrent topics in Jesús Molina's work include Pneumonia and Respiratory Infections (4 papers), Respiratory viral infections research (2 papers) and Microbial Metabolites in Food Biotechnology (1 paper). Jesús Molina is often cited by papers focused on Pneumonia and Respiratory Infections (4 papers), Respiratory viral infections research (2 papers) and Microbial Metabolites in Food Biotechnology (1 paper). Jesús Molina collaborates with scholars based in Spain, Denmark and United Kingdom. Jesús Molina's co-authors include Rosario Menéndez, José Barberán, Antoni Torres, Pedro Olaechea, Miquel Falguera, Alejandro Rodríguez, Martín Laclaustra, Luis Jesús Jiménez‐Borreguero, Valentı́n Fuster and Borja Ibáñez and has published in prestigious journals such as American Heart Journal, European Journal of Obstetrics & Gynecology and Reproductive Biology and Medicina Clínica.

In The Last Decade

Jesús Molina

7 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesús Molina Spain 5 101 48 41 38 32 7 188
Indah Kartika Murni Indonesia 7 79 0.8× 27 0.6× 25 0.6× 47 1.2× 9 0.3× 12 137
Jimei Chen China 10 109 1.1× 95 2.0× 80 2.0× 58 1.5× 13 0.4× 35 238
Rui Pereira Portugal 9 83 0.8× 21 0.4× 60 1.5× 23 0.6× 26 0.8× 17 185
Isabel João Portugal 9 47 0.5× 191 4.0× 46 1.1× 30 0.8× 44 1.4× 38 244
Daniela R. Crousillat United States 9 47 0.5× 175 3.6× 56 1.4× 49 1.3× 46 1.4× 35 263
Davinia Bennett United Kingdom 6 41 0.4× 67 1.4× 96 2.3× 32 0.8× 11 0.3× 7 174
Claudio Cavalli Italy 7 36 0.4× 19 0.4× 24 0.6× 32 0.8× 12 0.4× 14 157
Endale Tefera Ethiopia 8 94 0.9× 47 1.0× 46 1.1× 38 1.0× 37 1.2× 30 173
Soham Dasgupta United States 9 61 0.6× 86 1.8× 91 2.2× 94 2.5× 18 0.6× 45 254
Jordi Miatello France 7 94 0.9× 22 0.5× 64 1.6× 39 1.0× 10 0.3× 13 212

Countries citing papers authored by Jesús Molina

Since Specialization
Citations

This map shows the geographic impact of Jesús Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Molina more than expected).

Fields of papers citing papers by Jesús Molina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Molina. The network helps show where Jesús Molina may publish in the future.

Co-authorship network of co-authors of Jesús Molina

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Molina. A scholar is included among the top collaborators of Jesús Molina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Molina. Jesús Molina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rivero‐Calle, Irene, et al.. (2019). El nuevo calendario vacunal oficial del adulto no contempla la prevención de la neumonía neumocócica. Europe PMC (PubMed Central). 32(3). 281–283. 3 indexed citations
2.
Rivero‐Calle, Irene, Miriam Cebey‐López, Jacobo Pardo‐Seco, et al.. (2019). Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults (NEUMO-ES-RISK project). BMJ Open Respiratory Research. 6(1). e000359–e000359. 24 indexed citations
3.
Fernández‐Ortíz, Antonio, Luis Jesús Jiménez‐Borreguero, José L. Peñalvo, et al.. (2013). The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: Rationale and design. American Heart Journal. 166(6). 990–998. 72 indexed citations
4.
Torres, Antoni, José Barberán, Miquel Falguera, et al.. (2012). Guía multidisciplinar para la valoración pronóstica, diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Medicina Clínica. 140(5). 223.e1–223.e19. 44 indexed citations
5.
Lubrano, Amina, et al.. (2011). Follow-up after LLETZ: a study of 682 cases of CIN 2–CIN 3 in a single institution. European Journal of Obstetrics & Gynecology and Reproductive Biology. 161(1). 71–74. 34 indexed citations
6.
Miravitlles, Marc, Jesús Molina, & Max Brosa. (2007). Eficacia clínica del moxifloxacino en el tratamiento de las agudizaciones de la bronquitis crónica. Revisión sistemática y metaanálisis. Archivos de Bronconeumología. 43(1). 22–28. 8 indexed citations
7.
Molina, Jesús, et al.. (1991). [Utility of the L-alanine-aminopeptidase test for differentiating the cell wall structure of bacteria].. PubMed. 9(10). 637–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026